do compounded glp-1 drugs work New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these at scale. Our How GLP-1 medications are transforming
Description
Methods This was an exploratory study of the IIH:Pressure trial (ISTCRN 12678718)
Glucagon-like peptide-1 analogues inhibit proliferation and increase apoptosis of human prostate cancer cells in vitro
GLP-1, RA: glucagon-like peptide-1, receptor agonist
Each of the two GLP-1 molecules has a glycine substitution at the DPP-4 sensitive moieties
JAMA Intern Med 2022;182:513-9.ArticlePubMedPMC 40
